- Profile the patient: warm/cold × wet/dry. Most are warm & wet → diurese.
- Flash pulmonary edema with high BP → BiPAP + high-dose nitroglycerin, then diuretic.
- IV loop dose = 1–2.5× the home oral dose (DOSE). Furosemide-naive: 40–80 mg IV.
- Check response at 2 h (spot urine Na >50–70) and 6 h (UOP >100–150 mL/h). Weak response → double the dose, then add a thiazide or acetazolamide.
- Cold & wet / shock → ICU, inotrope; see cardiogenic shock.
- Keep GDMT unless shock or symptomatic hypotension. Start SGLT2i in hospital.
Pathophysiology in 60 seconds
⌄
- HF = high filling pressure (congestion) ± low output (hypoperfusion).
- Most admissions are fluid redistribution or accumulation over days: high LV pressure → pulmonary venous pressure → alveolar edema.
- Low output → kidneys sense "low volume" → RAAS + sympathetic + ADH → more salt and water retention → a vicious circle.
- Venous congestion (high CVP) hurts the kidney more than low output → creatinine often improves with diuresis.
perfused
Warm & dryCompensated. Optimize GDMT.
Warm & wetMost common (~70%). Diurese.
low output
Cold & dryRare. Careful fluids; look for other cause.
Cold & wetWorst prognosis. Inotrope ± pressor, then diurese. Think shock.
Congestion: orthopnea, JVD, edema, rales, hepatojugular reflux. Low perfusion: cool limbs, narrow pulse pressure, confusion, rising creatinine/lactate.
Diagnosis
⌄
- Clinical: dyspnea, orthopnea, PND, edema, JVD, rales, S3.
- BNP >100 / NT-proBNP >300 supports HF (lower in obesity; higher in CKD, AF, age).
- CXR: cephalization, Kerley B, effusions. POCUS: B-lines, plethoric IVC.
- TTE: EF, valves, RV, pericardium (new HF or change).
Find the trigger — "FAILURE": Forgot meds/salt · Arrhythmia (AF) / Anemia · Ischemia/infection · Lifestyle (salt, alcohol) · Upregulation (pregnancy, thyroid) · Renal failure · Embolism / Endocarditis. Plus: NSAIDs, TZDs, non-DHP CCB, uncontrolled HTN, valve disease.
Workup
⌄
ECG, troponin (flat mild elevation is common), BMP, Mg, CBC, BNP, TSH, iron studies (ferritin, TSAT), A1c, lipids, TTE. New cardiomyopathy → ischemic evaluation.
Management
⌄
| Step | Action |
|---|---|
| Start | Furosemide IV 1–2.5× home PO dose BID (or bolus + drip). Bumetanide 1 mg ≈ furosemide 40 mg IV |
| 2 h | Spot urine Na <50–70 mEq/L → poor response |
| 6 h | UOP <100–150 mL/h → poor response |
| Poor response | Double the loop dose (ceiling ~200–250 mg IV furosemide) |
| Still poor | Add metolazone 2.5–5 mg PO / chlorothiazide 500 mg IV, or acetazolamide 500 mg IV (ADVOR) |
| Refractory | Ultrafiltration / HF team |
- Goal: euvolemia, not a weight number. Net −1 to −3 L/day typical.
- Check BMP + Mg daily (K, Mg go down; Na can drop with thiazides).
- Creatinine rise ≤0.3–0.5 with good decongestion → keep going (permissive).
- BiPAP (or CPAP) right away.
- Nitroglycerin: SL 0.4–0.8 mg q5 min, then IV infusion starting ~50–100 mcg/min and titrate fast (high-dose strategy) to SBP ~140.
- Then IV loop diuretic. Many are not total-body overloaded — they are "volume-shifted."
- Avoid morphine (worse outcomes).
- Continue β-blocker, ARNI/ACEi/ARB, MRA unless shock, symptomatic hypotension, severe AKI/hyperkalemia.
- Hold β-blocker in cardiogenic shock or new cold & wet profile.
- Start SGLT2i once stable (EMPULSE: better outcomes, works in HFrEF and HFpEF).
- STRONG-HF: rapid up-titration before and soon after discharge → fewer readmissions and deaths.
- IV iron if ferritin <100 or 100–299 with TSAT <20% (HFrEF).
Pitfalls
⌄
- Under-dosing diuretics because "creatinine is up."
- Discharging still congested (weight ≠ euvolemia; check JVP, orthopnea).
- Stopping GDMT for asymptomatic soft BP.
- Missing hypokalemia/hypomagnesemia → arrhythmias.
- Fluid bolus to a "cold" HF patient without checking filling.
Board corner
⌄
| Stem | Answer |
|---|---|
| SBP 210, RR 34, frothy sputum, SpO₂ 84% | BiPAP + high-dose nitrates |
| Cool extremities, Cr rising, SBP 85, rales | Cold & wet → inotrope (dobutamine/milrinone) |
| Poor UOP after 80 mg IV furosemide | Double the dose before adding a second agent |
| HFrEF admission, BP 110/70, K 4.2 | Continue GDMT; start SGLT2i |
| Diuretic resistance + contraction alkalosis | Acetazolamide |
Discharge checklist
⌄
- ☐ Euvolemic on exam; oral diuretic tested ≥24 h
- ☐ GDMT started/up-titrated (all 4 pillars in HFrEF)
- ☐ BMP within 1 week; follow-up visit within 7 days
- ☐ Daily weights; call if +2 lb/day or +5 lb/week
- ☐ Na ~2 g, avoid NSAIDs; vaccines; cardiac rehab referral (HFrEF)
References
⌄
- Heidenreich PA, et al. 2022 AHA/ACC/HFSA HF guideline. Circulation. 2022;145:e895.
- McDonagh TA, et al. 2023 ESC HF focused update. Eur Heart J. 2023;44:3627.
- DOSE (NEJM 2011) · ADVOR (NEJM 2022) · EMPULSE (Nat Med 2022) · STRONG-HF (Lancet 2022).
- Mullens W, et al. Diuretics in HF with congestion (HFA position). Eur J Heart Fail. 2019.